Christopher J. Senner's Net Worth
$35.6 Million
Who is Christopher J. Senner?
Christopher J. Senner has an estimated net worth of $35.6 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., and Quince Therapeutics, Inc..
SEC CIK
Christopher J. Senner's CIK is 0001648367
Past Insider Trading and Trends
2021 was Christopher J. Senner's most active year for acquiring shares with 8 total transactions. Christopher J. Senner's most active month to acquire stocks was the month of August. 2020 was Christopher J. Senner's most active year for disposing of shares, totalling 13 transactions. Christopher J. Senner's most active month to dispose stocks was the month of October. 2024 saw Christopher J. Senner paying a total of $3,051,250.00 for 314,307 shares, this is the most they've acquired in one year. In 2024 Christopher J. Senner cashed out on 302,172 shares for a total of $4,534,722.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$25.80 | -$347,500.00 | 721.68K |
Aug 9
| |||
Form 4
| -4.03% | -30.31K |
$20.99 | -$636,206.90 | 721.68K |
May 15
| |||
Form 4
| +12.26% | 82.12K |
—
|
—
| 751.99K |
Feb 23
| |||
Form 4
| +9.54% | 58.32K |
$22.86 | -$499,765.32 | 669.87K |
Jan 11
| |||
Form 4
| +8.52% | 47.99K |
$22.27 | -$381,863.69 | 611.54K |
Sep 6
| |||
Form 4
| -1.41% | -8.07K |
$21.51 | -$173,671.74 | 563.56K |
Aug 15
| |||
Form 4
|
—
|
0
|
$17.67 | -$702,600.00 | 571.63K |
Aug 3 - Aug 4
| |||
Form 4
| -3.13% | -18.45K |
$19.18 | -$353,794.28 | 571.63K |
May 15
| |||
Form 4
| +16.92% | 85.41K |
—
|
—
| 590.08K |
Apr 3
| |||
Form 4
| -1.04% | -5.28K |
$18.08 | -$95,426.24 | 504.66K |
Feb 15
| |||
Form 4
| -1.56% | -8.07K |
$16.71 | -$134,916.54 | 509.94K |
Nov 15
| |||
Form 4
| +16.18% | 72.13K |
$12.72 | -$1,542,382.41 | 518.01K |
Aug 11
| |||
Form 4
| +5.81% | 24.49K |
$21.49 | -$173,510.26 | 445.88K |
Aug 3
| |||
Form 4
| -1.96% | -8.44K |
$20.08 | -$169,555.52 | 421.39K |
May 15
| |||
Form 4
| +21.47% | 75.98K |
—
|
—
| 429.83K |
Mar 4
| |||
Form 4
| -4.92% | -18.33K |
$18.59 | -$340,698.93 | 353.85K |
Feb 15
| |||
Form 4
| +4.01% | 14.36K |
$17.00 | -$87,227.00 | 372.18K |
Dec 15
| |||
Form 4
| -13.89% | -57.71K |
$18.10 | -$1,044,605.30 | 357.81K |
Nov 15
| |||
Form 4
| +6.13% | 23.99K |
$20.63 | -$176,860.99 | 415.53K |
Sep 30
| |||
Form 4
| +9.80% | 34.94K |
$12.00 | -$789,908.81 | 391.53K |
Sep 21
| |||
Form 4
| +21.94% | 64.15K |
—
|
—
| 356.59K |
Mar 4
| |||
Form 4
| -1.38% | -4.11K |
$21.91 | -$89,940.55 | 292.44K |
Feb 15
| |||
Form 4
| +20.75% | 50.95K |
$22.56 | -$410,727.36 | 296.55K |
Feb 3
| |||
Form 4
|
—
|
0
|
$14.33 | -$640,200.00 | 245.6K |
Scheduled
|
Jan 12
| ||
Form 4
| -5.25% | -13.60K |
$20.16 | -$274,115.52 | 245.6K |
Nov 15
| |||
Form 4
| +102.68% | 131.31K |
$21.79 | -$1,022,386.80 | 259.19K |
Oct 22
| |||
Form 4
|
—
|
0
|
$14.33 | -$213,400.00 | 127.88K |
Scheduled
|
Oct 8
| ||
Form 4
|
—
|
0
|
$14.33 | -$426,800.00 | 127.88K |
Scheduled
|
Sep 15
| ||
Form 4
| +5.95% | 7.18K |
$21.58 | -$55,374.28 | 127.88K |
Sep 2
| |||
Form 4
|
—
|
0
|
$14.74 | -$2,214,785.83 | 120.7K |
May 7 - May 8
| |||
Form 4
| +10.53% | 11.5K |
$17.67 | -$72,270.30 | 120.7K |
Dec 4
| |||
Form 4
| -9.01% | -10.82K |
$16.51 | -$178,621.69 | 109.2K |
Nov 15
| |||
Form 4
| +6.82% | 7.66K |
$19.26 | -$52,714.62 | 120.02K |
Sep 12
| |||
Form 4
| -24.40% | -36.26K |
$20.70 | -$750,602.70 | 112.36K |
May 3
| |||
Form 4
| -5.64% | -8.79K |
$19.70 | -$173,182.70 | 146.95K |
Nov 30
| |||
Form 4
| -4.75% | -7.76K |
$17.45 | -$135,481.80 | 155.74K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
| -1.67% | -2.76K |
$24.75 | -$68,359.50 | 162.5K |
Nov 15
| |||
Form 4
| +60.82% | 62.5K |
—
|
—
| 165.26K |
Oct 3
| |||
Form 4
|
—
|
0
|
$15.23 | -$2,313,000.00 | 102.76K |
Sep 12
| |||
Form 4
| -9.87% | -11.00K |
$22.80 | -$250,800.00 | 100.4K |
Mar 3
| |||
Form 4/A
| -17.52% | -26.75K |
$8.44 | -$394,578.44 | 125.98K |
Jul 15 - Sep 22
| |||
Form 4
| +15.07% | 20K |
—
|
—
| 152.73K |
Sep 22
| |||
Form 4
| +32.73% | 32.73K |
$4.20 | -$87,549.00 | 132.73K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quince Therapeutics, Inc. (QNCX) Snapshot price: $0.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||